A landmark deal for HIV jab
Focus on AfricaPlay episode
Show notes
A new HIV prevention drug will be made available at a lower cost in over 100 low-income countries within two years, including across Africa. It's a move expected to give millions access to the breakthrough treatment and potentially bring the world closer to ending the HIV/Aids epidemic. So, how affordable and effective is it?
Also, Zimbabwe continues on a quest to become Africa’s blueberry capital after recently signing a tariff free export agreement with China, one of the largest consumers of the fruit. What impact will it have on the country?
And why students in Europe are learning Hausa, a language spoken by millions of people in West Africa
Presenter: Charles Gitonga Producers: Yvette Twagiramariya and Patrcia Whitehorne in London. Madina Maishanu in Abuja. Technical Producer: Chris Ablakwa Senior Journalists: Sunita Nahar and Karnie Sharp Editors: Andre Lombard, Samuel Murunga, Maryam Abdalla and Alice Muthengi
